Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

MolecularHUB Gives Scientific Information on Fast-moving Diseases

Published: Thursday, October 25, 2012
Last Updated: Thursday, October 25, 2012
Bookmark and Share
A scientific gateway website that will provide molecular and genetic information on infectious and emerging diseases has been released by Purdue University.

The MolecularHUB site was announced Wednesday (Oct. 24) at the annual meeting of the Association for Molecular Pathology (AMP), which is being held in Long Beach, Calif.

James McGlothlin, a Purdue associate professor of health sciences and director of the site, said MolecularHUB will actively foster an environment of co-creation and collaboration. The goal of the site is to expand the current knowledge base of genetic markers, gene sequencing and molecular testing related to infectious diseases, chronic diseases and emerging diseases to help speed the identification and treatment of these diseases.

"With this site we have the opportunity to improve public health care and patient outcomes by providing free, easy access to the latest information," McGlothlin said. "The half-life of information in this field is very short; it's one of the fastest moving disciplines in modern science. So this site will keep professionals up-to-date with the latest scientific information."

The site,, is exclusively sponsored by BD (Becton Dickinson and Company), a Fortune 500 medical supply company.

"The goal is involve anyone working with molecular diagnostics so we can combine and leverage resources and capabilities," McGlothlin said. "This will allow us to standardize work practices and provide training and programs that will enhance scientific knowledge in this field."

Gregory Meehan, vice president for diagnostic systems and molecular diagnostics at BD Diagnostics, one of three divisions of BD, said the site has the potential to bring together medical and scientific communities.

"The valuable information and experiences of the global laboratory, scientific and academic community will come together through MolecularHUB in developing and sharing best practices across the spectrum of molecular-based diagnostic applications, laboratory efficiency, and clinical and economic outcomes," Meehan said.

The site is built on the Purdue-developed platform HUBzero, which has been used by more than 40 scientific, engineering and medical gateway sites as resources for scientific communities.

"MolecularHUB will be accessible to the more than 600,000 visitors of other hubs each year," McGlothlin said. "This will foster other opportunities for synergistic collaborations among disciplines such as engineering, laboratory design and ergonomics, and drug delivery."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Microsecond Raman Imaging Might Probe Cells, Organs for Disease
An advanced medical diagnostic tool for the early detection of cancer and other diseases.
Thursday, April 02, 2015
Keck Foundation to Fund Purdue Research into Spectroscopic Imaging
Ji-Xin Cheng leads a Purdue team awarded a $1 million W.M. Keck Foundation grant to develop a new type of imaging technology for cell and tissue analysis that could bring advanced medical diagnostics.
Tuesday, February 10, 2015
Cell-Detection System Promising for Medical Research, Diagnostics
Researchers are developing a system that uses tiny magnetic beads to quickly detect rare types of cancer cells circulating in a patient's blood.
Thursday, October 03, 2013
Purdue to Accelerate Drug Discovery, Development
Purdue Center for Drug Discovery adds to Purdue's strengths and the capacity to translate basic research into life-changing treatments.
Monday, September 16, 2013
Indiana Biosciences Research Institute Unveiled
Purdue University part of first industry-led collaborative life sciences research institute in the United States.
Monday, June 10, 2013
New Imaging Technology Could Reveal Cellular Secrets
Researchers have married two biological imaging technologies, creating a new way to learn how good cells go bad.
Friday, April 26, 2013
Sensor Detects Glucose in Saliva and Tears for Diabetes Testing
Researchers have created a new type of biosensor that can detect minute concentrations of glucose in saliva, tears and urine and might be manufactured at low cost because it does not require many processing steps to produce.
Thursday, September 13, 2012
Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos